Acceptability of levofloxacin, moxifloxacin and linezolid among children and adolescents treated for TB

por Winckler, J. L., Draper, H. R., Schaaf, H. S., van der Laan, L. E., Hesseling, A. C., Garcia-Prats, A. J.
Publicado en Int J Tuberc Lung Dis (2020)

Bioavailability of two licensed paediatric rifampicin suspensions: implications for quality control programmes

por McIlleron, H., Hundt, H., Smythe, W., Bekker, A., Winckler, J., van der Laan, L., Smith, P., Zar, H. J., Hesseling, A. C., Maartens, G., Wiesner, L., van Rie, A.
Publicado en Int J Tuberc Lung Dis (2016)